State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Back

ESC2025 Premium Access

State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Session: Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Topic: Cardiovascular Pharmacotherapy

Speaker: Professor D. Bhatt (New York, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)

52 presentations

12 followers

4 more presentations in this session

Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis

Speaker: Professor S. Mulvagh (Halifax, CA)

Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF

Speaker: Doctor R. Aggarwal (Boston, US)

Undertreatment of women with lipid-lowering therapies in four European countries: results from the prospective, non-interventional MILOS Study

Speaker: Professor I. Gouni-Berthold (Cologne, DE)

Effects of icosapent ethyl on risk and duration of hospitalizations and death in REDUCE-IT

Speaker: Doctor D. Bhatt (New York, US)

Access the full session

Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

Speakers: Professor D. Bhatt, Professor S. Mulvagh, Doctor R. Aggarwal, Professor I. Gouni-Berthold, Doctor D. Bhatt

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources